Lund Systemic Sclerosis Research Group
31 – 40 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
Multiple manifestations of systemic sclerosis affect walk distance
- Contribution to journal › Letter
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
- Contribution to journal › Article
-
Mark
Underfilling decreases left ventricular function in pulmonary arterial hypertension
- Contribution to journal › Article
- 2020
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
- Contribution to journal › Article
-
Mark
Type III, IV, and VI Collagens Turnover in Systemic Sclerosis – a Longitudinal Study
- Contribution to journal › Article
-
Mark
Successful lung transplantation in a patient with rheumatoid arthritis suffering from obliterative bronchiolitis
- Contribution to journal › Letter
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
- Contribution to journal › Article
